SARA CURTIS: Open Payments
NPI 1407251424 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 67 payments from 14 companies in 2025. Trend: 2023 $1,683 · 2024 $1,795 · 2025 $1,580
Food & beverage: $1,580
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $333 |
| Amgen Inc. | 7 | $197 |
| SCPHARMACEUTICALS INC. | 5 | $182 |
| E.R. Squibb & Sons, L.L.C. | 3 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| PFIZER INC. | 6 | $113 |
| Medtronic, Inc. | 1 | $110 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
Products named: LEQVIO, REPATHA, FUROSCIX, JARDIANCE, Kerendia, AURORA EV-ICD MRI SURESCAN, ELIQUIS, CAMZYOS.
Industry payments across MD — which companies pay providers there.
